NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/12/2023
Back to search
Official data from USPTO
BIOSYNTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
12/12/2023
Trademark type
Word
Nice classes
5
Filing date
06/13/2016
Registration date
09/12/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/12/2023
Last transaction
12/12/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/29/2006
First use in commerce
09/29/2006
Drawing code
4
Owner type
03
Owner location
Staad, CH
Examiner
GEARHART,DAVID JAMES
Law office
M30
Current location
TMO LAW OFFICE 112
Holders and representatives
Holders
Biosynth AG
Representatives
Tara Reedy Sliva DENTONS US LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; Chemical reagents for medical and veterinarian use; Chemical reagents for cultures of microorganisms for medical usein culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposesfor Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosiscoronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposesfor novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Chemical preparations for medical purposesfor immunology research; Organic chemical preparations for medical purposesimmunomodulatory compounds with anti-inflammatory properties; Organic chemical preparations for medical laboratory analysis purposesfor medical detectionidentification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposesfor medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposesused as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms; Chemical preparations for medical laboratory analysis purposesfor medical detection of pathogenic bacteriavarious strains of ListeriaClostridiumBacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposesfor the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureusin particular for Methicillin-resistant Staphylococcus aureus (MRSA); Medical enzyme
Publications
History of USPTO decisions and trademark events.
30 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/12/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/12/2023
E815
TEAS SECTION 8 & 15 RECEIVED
06/14/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/10/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/09/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/09/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/05/2017
IUAF
USE AMENDMENT FILED
07/11/2017
EISU
TEAS STATEMENT OF USE RECEIVED
07/11/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/11/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/17/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2016
PUBO
PUBLISHED FOR OPPOSITION
11/22/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/18/2016
ALIE
ASSIGNED TO LIE
10/17/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/30/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
09/27/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/27/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
09/27/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/27/2016
DOCK
ASSIGNED TO EXAMINER
09/22/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/20/2016
NWAP
NEW APPLICATION ENTERED
06/16/2016
Continuous trademark protection
Get notified about every new filing that threatens BIOSYNTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.